Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-05-08

Last Posted Date: 2013-06-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00004059

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

Phase 2

Completed

Conditions: Leukemia

First Posted Date: 2003-05-08

Last Posted Date: 2013-06-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT00004052

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

Polyglutamate Camptothecin in Treating Patients With Advanced Cancer

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2003-05-07

Last Posted Date: 2013-05-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00059917

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

Phase 1

Completed

Conditions: Lymphoma

First Posted Date: 2003-05-07

Last Posted Date: 2013-05-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00059995

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus, Ohio, United States

Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer

Not Applicable

Completed

Conditions: Anal Cancer
Colorectal Cancer
Perioperative/Postoperative Complications

Interventions: Procedure: conventional surgery
Procedure: management of therapy complications

First Posted Date: 2003-05-07

Last Posted Date: 2013-02-27

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 4

Registration Number: NCT00059891

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

First Posted Date: 2003-05-07

Last Posted Date: 2013-07-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00059904

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer

Phase 2

Completed

Conditions: Breast Cancer
Lung Cancer
Prostate Cancer

First Posted Date: 2003-05-07

Last Posted Date: 2013-01-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Registration Number: NCT00059943

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Adjuvant Hepatic Arterial Infusion and Combination Chemotherapy in Treating Patients With Resectable Hepatic Metastases From Colorectal Cancer

Phase 1

Active, not recruiting

Conditions: Colorectal Cancer
Metastatic Cancer

Interventions: Drug: FOLFOX regimen
Drug: dexamethasone
Drug: floxuridine
Drug: fluorouracil
Drug: leucovorin calcium
Drug: oxaliplatin
Procedure: adjuvant therapy
Procedure: conventional surgery

First Posted Date: 2003-05-07

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 38

Registration Number: NCT00059930

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

Phase 3

Completed

Conditions: Anemia
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm

First Posted Date: 2003-04-25

Last Posted Date: 2013-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 275

Registration Number: NCT00003341

Locations: 🇺🇸
Comprehensive Cancer Centers of the Desert, Palm Springs, California, United States
🇺🇸
Division of Oncology, Palo Alto, California, United States
🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

and more 15 locations

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2

Completed

Conditions: Melanoma (Skin)

First Posted Date: 2003-04-25

Last Posted Date: 2013-06-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 80

Registration Number: NCT00003346

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy